glp 1 agonist eli lilly & Co. presents new GLP-1R agonists FDA just approved orforglipron (Foundayo),

doi: 10.1159/000510677 16 KellarDLockhartSNAisenPRamanRRissmanRABrewerJet al

Intracranial pressure after subarachnoid hemorrhage

Medications such as semaglutide and liraglutide have been noted to provide benefits, including improved glycemic control, weight loss, and a reduction in cardiovascular risk

Current research has not established a minimum effective dose, though studies most commonly examine 5 to 10 grams of allulose

Clinical trials proving their effectiveness also included education on nutrition and physical activity, which are essential for achieving meaningful results

Recovery-phase support to stabilize the nervous system post-attack